|
2020-10-14 |
2020-10-10 |
B
Purchase
|
IONIS PHARMACEUTICALS INC
Large shareholder
|
21,237,715
+27.6%
18.15
USD 385,464,527
|
21,237,715
+27.6%
|
18.15
|
USD 385,464,527
|
|
|
2020-09-24 |
2020-09-22 |
S
Sale
|
McDevitt Damien
Chief Executive Officer
Executive Director
|
8,709
-3.5%
18.12
USD 157,807
|
8,709
-3.5%
|
18.12
|
USD 157,807
|
|
|
2020-09-24 |
2020-09-22 |
S
Sale
|
Jenne Kyle
Chief Commercial Officer
Officer
|
720
-1.4%
18.12
USD 13,046
|
720
-1.4%
|
18.12
|
USD 13,046
|
|
|
2020-09-24 |
2020-09-22 |
S
Sale
|
Patterson Joshua F.
General Counsel
Officer
|
319
-1.2%
18.12
USD 5,780
|
319
-1.2%
|
18.12
|
USD 5,780
|
|
|
2020-07-20 |
2020-07-17 |
S
Sale
|
Patterson Joshua F.
General Counsel
Officer
|
263
-1.0%
12.50
USD 3,288
|
263
-1.0%
|
12.50
|
USD 3,288
|
|
|
2020-03-25 |
2020-03-23 |
S
Sale
|
Patterson Joshua F.
General Counsel
Officer
|
335
-2.2%
11.76
USD 3,938
|
335
-2.2%
|
11.76
|
USD 3,938
|
|
|
2020-03-25 |
2020-03-23 |
S
Sale
|
O'Dea Louis
Chief Medical Officer
Officer
|
3,198
-4.9%
11.75
USD 37,579
|
3,198
-4.9%
|
11.75
|
USD 37,579
|
|
|
2020-03-25 |
2020-03-23 |
S
Sale
|
McDevitt Damien
Chief Executive Officer
Executive Director
|
9,417
-3.7%
11.75
USD 110,649
|
9,417
-3.7%
|
11.75
|
USD 110,649
|
|
|
2020-03-25 |
2020-03-23 |
S
Sale
|
Jenne Kyle
Chief Commercial Officer
Officer
|
779
-1.5%
11.75
USD 9,153
|
779
-1.5%
|
11.75
|
USD 9,153
|
|
|
2019-07-17 |
2019-07-15 |
S
Sale
|
Boyce Sarah
President
Executive Director
|
1,819
-8.4%
23.52
USD 42,783
|
1,819
-8.4%
|
23.52
|
USD 42,783
|
|
|
2019-04-09 |
2019-04-08 |
PS
Planned sale
|
Soteropoulos Paula
Chief Executive Officer
Executive Director
|
1,787
-100.0%
32.17
USD 57,480
|
1,787
-100.0%
|
32.17
|
USD 57,480
|
|
|
2019-04-09 |
2019-04-08 |
PS
Planned sale
|
Goldberg Jeff Marc
Chief Operating Officer
|
20,000
-87.4%
31.72
USD 634,418
|
20,000
-87.4%
|
31.72
|
USD 634,418
|
|
|
2019-04-09 |
2019-04-05 |
PS
Planned sale
|
Soteropoulos Paula
Chief Executive Officer
Executive Director
|
30,000
-100.0%
32.11
USD 963,300
|
30,000
-100.0%
|
32.11
|
USD 963,300
|
|
|
2019-04-09 |
2019-04-05 |
PS
Planned sale
|
Goldberg Jeff Marc
Chief Operating Officer
|
30,000
-91.2%
31.71
USD 951,300
|
30,000
-91.2%
|
31.71
|
USD 951,300
|
|
|
2019-03-07 |
2019-03-06 |
PS
Planned sale
|
Soteropoulos Paula
Chief Executive Officer
Executive Director
|
18,386
-100.0%
32.14
USD 590,856
|
18,386
-100.0%
|
32.14
|
USD 590,856
|
|
|
2018-04-19 |
2018-04-17 |
B
Purchase
|
IONIS PHARMACEUTICALS INC
Large shareholder
|
10,666,666
+20.0%
18.75
USD 199,999,988
|
10,666,666
+20.0%
|
18.75
|
USD 199,999,988
|
|
|
2017-07-21 |
2017-07-19 |
B
Purchase
|
IONIS PHARMACEUTICALS INC
Large shareholder
|
3,125,000
+7.4%
8.00
USD 25,000,000
|
3,125,000
+7.4%
|
8.00
|
USD 25,000,000
|
|
